Topic: sterile injectables
Mylan is recalling a chemo drug and Hospira a commonly used solution because potentially dangerous particulate has been discovered in vials.
Japan’s Nichi-Iko Pharmaceutical and its U.S. operation Sagent Pharmaceuticals have bought a plant in North Carolina from Xellia.
Just weeks after being hit with an FDA letter for its Illinois manufacturing operations, the FDA tagged a different Akorn plant with a Form 483.
Endo says it has dropped its $190 million buyout of sterile injectables company Somerset Therapeutics as approvals from India became uncertain.
The FDA has made another trip to the key Aurobindo sterile manufacturing facility in India and has again found it lacking.
Healthcare management company Premier has set up a new subsidiary to focus on helping providers with drug shortages.
Hospitals can expect ongoing shortages of some key drugs as Pfizer continues to work on its troubled sterile injectables plant.
The American Hospital Association has crafted a lengthy list of suggestions for addressing drug shortages that include both the carrot and the stick.
FDA slaps Akorn with warning letter following an inspection of its sterile injectables plant in Illinois.
Pfizer's plan to close two legacy Hospira plants in India puts 1,700 jobs stationed there at risk.